Item 5.02. Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

On November 4, 2020, the Board of Directors (the "Board") of Tenet Healthcare Corporation (the "Company") appointed the Company's President and Chief Operating Officer, Saum Sutaria, M.D., to the Board effective immediately. The size of the Board increased from ten to eleven directors upon the effectiveness of Dr. Sutaria's appointment. Dr. Sutaria's initial term will expire concurrently with the terms of the other members of the Board, and Board members will stand for annual election at the Company's 2021 Annual Meeting of Shareholders. Dr. Sutaria will not serve on any committee of the Board.

As an executive officer of the Company, Dr. Sutaria will not receive compensation for his service on the Board. Dr. Sutaria is not party to any material plan, contract, or arrangement with the Company other than those related to his compensation as described in the Company's proxy statement filed with the Securities and Exchange Commission on April 17, 2020. There are no arrangements or understandings pursuant to which Dr. Sutaria was appointed to the Board, and Dr. Sutaria is not a party to any transaction with the Company reportable under Item 404(a) of Regulation S-K under the Securities Act of 1933.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses